Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†

Cited by (1,000)

Items 101–200 of 1,000

1. Macrophage function in obesity-induced inflammation and insulin resistance
   Mario Lauterbach, Frank Thomas Wunderlich · 2017 · Pflügers Archiv - European Journal of Physiology
2. Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans
   Itoh, Michiko, Kato, Hideaki, Suganami, Takayoshi, Konuma, Kuniha, Marumoto, Yoshio, Terai, Shuji, Sakugawa, Hiroshi, Kanai, Sayaka, Hamaguchi, Miho, Fukaishi, Takahiro et al. · 2013 · PLoS ONE
3. Molecular Pathogenesis of NASH
   Alessandra Caligiuri, Alessandra Gentilini, Fabio Marra · 2016 · International Journal of Molecular Sciences
4. Intermittent Hypoxia Exacerbates Metabolic Effects of Diet‐Induced Obesity
   Drager, Luciano F., Li, Jianguo, Reinke, Christian, Bevans‐Fonti, Shannon, Jun, Jonathan C., Polotsky, Vsevolod Y. · 2011 · Obesity
5. Dual PPAR α/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
   Mukul Rameshchandra Jain, Suresh R. Giri, Bibhuti Bhoi, Chitrang J. Trivedi, Akshyaya Rath, Rohan Rathod, Ramchandra K. Ranvir, Shekhar B. Kadam, Hiren Patel, Prabodha K. Swain et al. · 2017 · Liver International
6. Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
   Mells, Jamie E., Fu, Ping P., Sharma, Shvetank, Olson, Darin, Cheng, Lihong, Handy, Jeffrey A., Saxena, Neeraj K., Sorescu, Dan, Anania, Frank A. · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
7. Novel therapeutic targets for cholestatic and fatty liver disease
   Trauner, Michael, Fuchs, Claudia Daniela · 2022 · Gut
8. Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments
   Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, Sakura Iida, Hisayuki Katsuyama · 2023 · International Journal of Molecular Sciences
9. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent
   Lay T. Gan, Derrick M. Van Rooyen, Mark E. Koina, Robert S. McCuskey, Narcissus Teoh, Geoffrey C. Farrell · 2014 · Journal of Hepatology
10. Nonalcoholic fatty liver disease: Evolving paradigms
    Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi · 2017 · World Journal of Gastroenterology
11. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease
    Maryann Maximos, Fernando Bril, Paola Portillo-Sánchez, Romina Lomonaco, Beverly Orsak, Diane Biernacki, Amitabh Suman, Michelle H. Weber, Kenneth J. Cusi · 2014 · Hepatology
12. Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review
    Abdulrahman Ismaiel, Dan Lucian Dumitrascu · 2019 · Frontiers in Medicine
13. The evolving role of liver sinusoidal endothelial cells in liver health and disease
    McConnell, Matthew J., Kostallari, Enis, Ibrahim, Samar H., Iwakiri, Yasuko · 2023 · Hepatology
14. Role of Autophagy in Cancer Prevention
    Hsin-Yi Chen, Eileen White · 2011 · Cancer Prevention Research
15. Therapeutic Landscape for NAFLD in 2020
    Brent A. Neuschwander‐Tetri · 2020 · Gastroenterology
16. Targeting fatty acid metabolism to improve glucose metabolism
    Stinkens, R., Goossens, G. H., Jocken, J. W. E., Blaak, E. E. · 2015 · Obesity Reviews
17. Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers
    Hwan‐Woo Park, Haeli Park, Ian A. Semple, Insook Jang, Seung‐Hyun Ro, Myungjin Kim, Victor A. Cazares, Edward L. Stuenkel, Jung‐Jae Kim, Jeong Sig Kim et al. · 2014 · Nature Communications
18. Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH
    Qianqian Guo, Kunimaro Furuta, Fabrice Lucien, Luz Helena Gutierrez Sanchez, Petra Hirsova, Anuradha Krishnan, Ayano Kabashima, Kevin D. Pavelko, Benjamin J. Madden, Husam Alhuwaish et al. · 2019 · Journal of Hepatology
19. Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
    Hsu‐Wen Chao, Shi-Wei Chao, Heng Lin, Hui‐Chen Ku, Ching‐Feng Cheng · 2019 · International Journal of Molecular Sciences
20. Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease
    Farrell, Geoffrey C., Haczeyni, Fahrettin, Chitturi, Shivakumar · 2018 · Advances in Experimental Medicine and Biology
21. From fatty liver to fibrosis: A tale of “second hit”
    Metin Başaranoğlu · 2013 · World Journal of Gastroenterology
22. Nonalcoholic steatohepatitis: a search for factual animal models
    Sanches, Sheila Cristina L., Ramalho, Leandra Naira Z., Augusto, Marlei Josiele, da Silva, Deisy Mara, Ramalho, Fernando Silva · 2015 · BioMed Research International
23. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy
    Fuyang Zhang, Shihao Zhao, Wenjun Yan, Yunlong Xia, Xiyao Chen, Wei Wang, Jinglong Zhang, Chao Gao, Cheng Yun Peng, Feng Yan et al. · 2016 · EBioMedicine
24. Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2
    Yoon‐Kwang Lee, Jung Eun Park, Mikang Lee, James P. Hardwick · 2018 · Liver Research
25. Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
    Laursen, Tea L, Hagemann, Christoffer A, Wei, Chunshan, Kazankov, Konstantin, Thomsen, Karen L, Knop, Filip K, Grønbæk, Henning · 2019 · World Journal of Hepatology
26. Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
    Xingyong Wan, Chengfu Xu, Chaohui Yu, Youming Li · 2016 · Canadian Journal of Gastroenterology and Hepatology
27. Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet
    Joel Richard Garbow, Jason M. Doherty, Rebecca C. Schugar, Sarah Travers, Mary L. Weber, Anna E. Wentz, Nkiruka Ezenwajiaku, David G. Cotter, Elizabeth M. Brunt, Peter A. Crawford · 2011 · American Journal of Physiology-Gastrointestinal and Liver Physiology
28. Non-alcoholic steatohepatitis: a microbiota-driven disease
    Alexander Rupert Moschen, Susanne Kaser, Herbert Tilg · 2013 · Trends in Endocrinology and Metabolism
29. Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression
    Liang Guo, Peng Zhang, Zhimin Chen, Houjun Xia, Siming Li, Yanqiao Zhang, Sune Kobberup, Weiping Zou, Jiandie D. Lin · 2017 · Journal of Clinical Investigation
30. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo
    Chunlai Zeng, Peng Zhong, Yunjie Zhao, Karvannan Kanchana, Yali Zhang, Zia Ali Khan, Subrata Chakrabarti, Lianpin Wu, Jingying Wang, Guang Liang · 2014 · Journal of Molecular and Cellular Cardiology
31. Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis
    Michiko Itoh, Takayoshi Suganami, Nobutaka Nakagawa, Miyako Tanaka, Yukio Yamamoto, Yasutomi Kamei, Shuji Terai, Isao Sakaida, Yoshihiro Ogawa · 2011 · American Journal Of Pathology
32. Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver Injury
    Tarek Moustafa, Peter Fickert, Christoph Magnes, Christian Guelly, Andrea Thueringer, Saša Frank, Dagmar Kratky, Wolfgang Sattler, Helga Reicher, Frank Michael Sinner et al. · 2011 · Gastroenterology
33. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10–deficient mice
    Andrew M. Miller, Hua Wang, Adeline Bertola, Ogyi Park, Norio Horiguchi, Sung Hwan Ki, Shi Yin, Fouad Lafdil, Bin Gao · 2011 · Hepatology
34. Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis
    Xu-Yun Zhao, Xuelian Xiong, Tongyu Liu, Lin Mi, Xiaoling Peng, Crystal Rui, Liang Guo, Siming Li, Xiaoying Li, Jiandie D. Lin · 2018 · Nature Communications
35. Periodontitis, chronic liver diseases, and the emerging oral‐gut‐liver axis
    Emmanuel Albuquerque‐Souza, Sinem E. Sahingur · 2022 · Periodontology 2000
36. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action
    Eleonora Scorletti, Christopher D. Byrne · 2018 · Molecular Aspects of Medicine
37. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway
    Meng Li, Chengfu Xu, Junping Shi, Jiexia Ding, Xingyong Wan, Dahua Chen, Jianguo Gao, Chunxiao Li, Jie Zhang, Yiming Lin et al. · 2017 · Gut
38. Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches
    Romina Lomonaco, Nishanth E. Sunny, Fernando Bril, Kenneth J. Cusi · 2013 · Drugs
39. NAFLD: Reporting Histologic Findings in Clinical Practice
    Elizabeth M. Brunt, David Erwin Kleiner, Danielle H. Carpenter, Mary Eugenia Rinella, Stephen A. Harrison, Rohit Seth Loomba, Zobair M. Younossi, Brent A. Neuschwander‐Tetri, Arun Jayant Sanyal · 2020 · Hepatology
40. Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
    Desai, Bhavna N., Singhal, Garima, Watanabe, Mikiko, Stevanovic, Darko, Lundasen, Thomas, Fisher, ffolliott M., Mather, Marie L., Vardeh, Hilde G., Douris, Nicholas, Adams, Andrew C. et al. · 2017 · Molecular Metabolism
41. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis
    Ooi, Geraldine J., Meikle, Peter J., Huynh, Kevin, Earnest, Arul, Roberts, Stuart K., Kemp, William, Parker, Benjamin L., Brown, Wendy, Burton, Paul, Watt, Matthew J. · 2021 · Journal of Hepatology
42. The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis
    Mithun Sharma, Shasikala Mitnala, Ravikanth Vishnubhotla, Rathin Mukherjee, D. Nageshwar Reddy, Padaki Nagaraja Rao · 2015 · Journal of Clinical and Experimental Hepatology
43. Nonalcoholic Fatty Liver Disease
    Fernando Bril, Kenneth J. Cusi · 2016 · Endocrinology and Metabolism Clinics of North America
44. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
    Romina Lomonaco, Fernando Bril, Paola Portillo-Sánchez, Carolina Ortiz‐Lopez, Beverly Orsak, Diane Biernacki, Margaret C. Lo, Amitabh Suman, Michelle H. Weber, Kenneth J. Cusi · 2016 · Diabetes Care
45. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats
    Jiali Liu, Lina Han, Leilei Zhu, Yerong Yu · 2016 · Lipids in Health and Disease
46. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C
    Lima-Cabello, Elena, García-Mediavilla, María Victoria, Miquilena-Colina, María E., Vargas-Castrillón, Javier, Lozano-Rodríguez, Tamara, Fernández-Bermejo, Miguel, Olcoz, José Luis, González-Gallego, Javier, García-Monzón, Carmelo, Sánchez-Campos, Sonia · 2011 · Clinical Science
47. Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic Review
    Elina M. Petäjä, Hannele Yki‐Järvinen · 2016 · International Journal of Molecular Sciences
48. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease
    Jump, Donald B., Lytle, Kelli A., Depner, Christopher M., Tripathy, Sasmita · 2018 · Pharmacology & Therapeutics
49. The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease
    Myeong Jun Song, Harmeet Malhi · 2019 · Pharmacology & Therapeutics
50. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity
    Xu Chen, Hongliang Xue, Wanjun Fang, Ke Chen, Shen Chen, Wenqi Yang, Tianran Shen, Xuechen Chen, Peiwen Zhang, Wenhua Ling · 2018 · Redox Biology
51. Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly
    Gan, Lay, Chitturi, Shivakumar, Farrell, Geoffrey C. · 2011 · Current Gerontology and Geriatrics Research
52. Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity
    Sanda Win, Tin Aung Than, Bao Han A. Le, Carmen García‐Ruiz, José Carlos Fernández-Checa, Neil Kaplowitz · 2015 · Journal of Hepatology
53. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions
    Kenneth J. Cusi · 2016 · Diabetologia
54. Hypoxia causes triglyceride accumulation via HIF-1-mediated stimulation of lipin 1 expression
    Ilias Mylonis, Hiroshi Sembongi, Christina D. Befani, Panagiotis Liakos, Symeon Siniossoglou, George Simos · 2012 · Journal of Cell Science
55. Insulin Resistance, Ceramide Accumulation, and Endoplasmic Reticulum Stress in Human Chronic Alcohol-Related Liver Disease
    Lisa Longato, Kelsey Ripp, Mashiko Setshedi, Miroslav Dostálek, Fatemeh Akhlaghi, Mark Branda, Jack R. Wands, Suzanne M. de la Monte · 2012 · Oxidative Medicine and Cellular Longevity
56. Bisphenol A Exposure May Induce Hepatic Lipid Accumulation via Reprogramming the DNA Methylation Patterns of Genes Involved in Lipid Metabolism
    Zhang-Hong Ke, Jiexue Pan, Lu‐Yang Jin, Haiyan Xu, Tiantian Yu, Kamran Ullah, Tanzil Ur Rahman, Jun Tao Ren, Yi Cheng, Xinyan Dong et al. · 2016 · Scientific Reports
57. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis
    Francesco Bellanti, Rosanna Villani, Antonio Facciorusso, Gianluigi Vendemiale, Gaetano Serviddio · 2017 · Free Radical Biology and Medicine
58. Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance
    Maxwell A. Ruby, Julie Massart, Devon M. Hunerdosse, Milena Schönke, Jorge C. Correia, Sharon M. Louie, Jorge Lira Ruas, Erik B. Näslund, Daniel K. Nomura, Juleen Rae Zierath · 2017 · Cell Reports
59. Lipogenesis in cancer progression (Review)
    Cathérine Mounier, Lamia Bouraoui, Éric Rassart · 2014 · International Journal of Oncology
60. Physiology and pathophysiology of liver lipid metabolism
    Francesca Romana Ponziani, Silvia Pecere, Antonio Gasbarrini, Veronica Ojetti · 2015 · Expert Review of Gastroenterology & Hepatology
61. Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
    Derrick M. Van Rooyen, Lay T. Gan, Matthew M. Yeh, W. Geoffrey Haigh, Claire Z. Larter, George N. Ioannou, Narci Teoh, Geoffrey C. Farrell · 2013 · Journal of Hepatology
62. Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity
    INSERM, U1241, Université de Rennes 1, Rennes, France, Bernard Fromenty · 2017 · Journal of Clinical and Translational Research
63. Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment
    Nathalie Carvalho Leite · 2014 · World Journal of Gastroenterology
64. Nonalcoholic fatty liver disease and obstructive sleep apnea
    Judith Aron‐Wisnewsky, Karine Clément, Jean‐Louis Pépin · 2016 · Metabolism
65. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Chanbin Lee, Ji‐Eun Kim, Youngmi Jung · 2019 · Cells
66. Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents
    Maximilian Hatting, Gang Zhao, Fabienne Schumacher, Gernot Sellge, Malika Al Masaoudi, Nikolaus Gaβler, Mark V. Boekschoten, Michael M. Müller, Christian Liedtke, Francisco Javier Cubero et al. · 2013 · Hepatology
67. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet
    Naoki Tanaka, Shogo Takahashi, Yuan Zhang, Kristopher W. Krausz, Philip B. W. Smith, Andrew D. Patterson, Frank J. Gonzalez · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
68. Glyphosate-induced lipid metabolism disorder contributes to hepatotoxicity in juvenile common carp
    Jingbo Liu, Chenyu Dong, Zhenzhen Zhai, Liang Tang, Lin Wang · 2020 · Environmental Pollution
69. Nonalcoholic steatohepatitis
    Jörn Markus Schattenberg, Detlef Schuppan · 2011 · Current Opinion in Lipidology
70. Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders
    Stephen L. Pinkosky, Pieter H.E. Groot, Narendra D. Lalwani, Gregory R. Steinberg · 2017 · Trends in Molecular Medicine
71. Effects of Stigmasterol and β-Sitosterol on Nonalcoholic Fatty Liver Disease in a Mouse Model: A Lipidomic Analysis
    Simin Feng, Ling Gan, Chung Shu Yang, Anna B. Liu, Wenyun Lu, Ping Shao, Zhuqing Dai, Peilong Sun, Zisheng Luo · 2018 · Journal of Agricultural and Food Chemistry
72. Cytokines in alcoholic liver disease
    Leon An, Xiaodong Wang, A. Cederbaum · 2012 · Archives of Toxicology
73. Acetyl‐coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double‐blind, crossover study
    Kathryn Stiede, Wenyan Miao, Heather Blanchette, Carine Beysen, Geraldine C. B. Harriman, H. James Harwood, Heather Kelley, Rosana Kapeller, Tess Schmalbach, William Westlin · 2017 · Hepatology
74. Di-2-ethylhexyl phthalate (DEHP) induced lipid metabolism disorder in liver via activating the LXR/SREBP-1c/PPARα/γ and NF-κB signaling pathway
    Yue-Qiang Huang, Yi-Xi Tang, Bai-Hao Qiu, Milton Talukder, Xue‐Nan Li, Jin‐Long Li · 2022 · Food and Chemical Toxicology
75. Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease
    Zhang Wenfeng, Yakun Wu, Mu Di, Gong Jianping, Chuanxin Wu, Chun Huang · 2014 · Annals of Hepatology
76. Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues
    Miguel Baena, Gemma Sangüesa, Alberto Dávalos, María-Jesús Latasa, Aleix Sala‐Vila, Rosa María Sánchez, Núria Roglans, Juan Carlos Laguna, Marta Alegret · 2016 · Scientific Reports
77. Role of aramchol in steatohepatitis and fibrosis in mice
    Marta Iruarrizaga‐Lejarreta, Marta Varela‐Rey, David Fernández‐Ramos, Ibon Martínez‐Arranz, Teresa C. Delgado, Jorge Simón, Virginia Gutiérrez‐de Juan, Laura delaCruz‐Villar, Mikel Azkargorta, José Luis Lavín et al. · 2017 · Hepatology Communications
78. Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis
    Zhu, Changyu, Tabas, Ira, Schwabe, Robert F., Pajvani, Utpal B. · 2021 · Nature Reviews Gastroenterology & Hepatology
79. Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis
    Julia Starmann, Maria Fälth, Walter Spindelboeck, Katja-Lauren Lanz, Carolin Lackner, Kurt Zatloukal, Michael A Trauner, Holger Sültmann · 2012 · PLoS ONE
80. Curcumin analog CUR5–8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity
    Eun Soo Lee, Mi-Hye Kwon, Hong Min Kim, Ho Bum Woo, Chan Mug Ahn, Choon Hee Chung · 2019 · Metabolism
81. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment
    Anna Alisi, Stefano Cianfarani, Melania Manco, Carlo Virginio Agostoni, Valério Nobili · 2011 · Annals of Medicine
82. Fibrosis Reduces Severity of Acute-on-Chronic Pancreatitis in Humans
    Chathur Acharya, Rachel A. Cline, Deepthi Jaligama, Pawan Noel, James P. DeLany, Kyongtae T. Bae, Alessandro Furlan, Catherine J. Baty, Jenny M. Karlsson, Bedda L. Rosario et al. · 2013 · Gastroenterology
83. Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism
    Kyung Eun Kim, Youngae Jung, Soonki Min, Miso Nam, Rok Won Heo, Byeong Tak Jeon, Dae Hyun Song, Chin‐ok Yi, Eun Ae Jeong, Hwajin Kim et al. · 2016 · Scientific Reports
84. Nonalcoholic fatty liver disease – current status and future directions
    Demir, Münevver, Lang, Sonja, Steffen, Hans‐Michael · 2015 · Journal of Digestive Diseases
85. Silencing of FABP 1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
    Takako Mukai, Miki Egawa, Tamaki Takeuchi, Hitoshi Yamashita, Tatsuya Kusudo · 2017 · FEBS Open Bio
86. Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD
    Yufeng Hu, Wenzhi He, Yongping Huang, Hui Xiang, Juan Guo, Yan Che, Xu Cheng, Fengjiao Hu, Manli Hu, Tengfei Ma et al. · 2021 · Hepatology
87. Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease
    Chao Sun, Jian‐Gao Fan, Liang Qiao · 2015 · International Journal of Molecular Sciences
88. Metabolic Inflammation-Differential Modulation by Dietary Constituents
    Claire L. Lyons, Elaine B. Kennedy, Helen M. Roche · 2016 · Nutrients
89. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p
    Zhibo Zhao, Zhong Alan Li, Peizhi Li, Kun He, Chan Qiu, Lei Zhao, Jianping Gong · 2019 · Experimental Cell Research
90. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease
    Carla Guzmán, Marta Benet, Sandra Pisonero‐Vaquero, Marta Moya, María Victoria García‐Mediavilla, Maria Luz Martínez‐Chantar, Javier González‐Gallego, José Vicente Castell, Sonia Sánchez‐Campos, Ramiro Jover · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
91. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease
    Kun Huang, Meng Du, Xin Tan, Ling Yang, Xiangrao Li, Yuhan Jiang, Cheng Wang, Fengxiao Zhang, Feng Zhu, Min Cheng et al. · 2016 · Journal of Hepatology
92. The selective peroxisome proliferator–activated receptor‐delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice
    Fahrettin Haczeyni, Hans Wang, Vanessa Barn, Auvro R. Mridha, Matthew M. Yeh, W. Geoffrey Haigh, George N. Ioannou, Yun‐Jung Choi, Charles A. McWherter, Narci Teoh et al. · 2017 · Hepatology Communications
93. Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients
    Alexander Wree, Martin Schlattjan, Lars P. Bechmann, Thierry Claudel, Jan‐Peter Sowa, Tatjana Stojaković, Hubert Scharnagl, Harald C. Köfeler, Hideo Andreas Baba, Guido Gerken et al. · 2014 · Metabolism
94. Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and Humans
    Chao‐Wei Huang, Yi-Shan Chien, Yu-Jen Chen, Kolapo Matthew Ajuwon, Harry John Mersmann, Shih‐Torng Ding · 2016 · International Journal of Molecular Sciences
95. Oral Formulation of Angiotensin-(1–7) Improves Lipid Metabolism and Prevents High-Fat Diet–Induced Hepatic Steatosis and Inflammation in Mice
    John David Feltenberger, João Marcus Oliveira Andrade, Alanna Fernandes Paraíso, Lucas Oliveira Barros, Aristides Batista Maia Filho, Rubén D. Sinisterra, Frederico B. De Sousa, André Luiz Sena Guimarães, Alfredo Maurício Batista de Paula, Maria José Campagnole‐Santos et al. · 2013 · Hypertension
96. Protective properties of milk sphingomyelin against dysfunctional lipid metabolism, gut dysbiosis, and inflammation
    Gregory H. Norris, Marine Milard, Marie‐Caroline Michalski, Christopher N. Blesso · 2019 · The Journal of Nutritional Biochemistry
97. Nuclear receptors linking metabolism, inflammation, and fibrosis in nonalcoholic fatty liver disease
    Puengel, Tobias, Liu, Hanyang, Guillot, Adrien, Heymann, Felix, Tacke, Frank, Peiseler, Moritz · 2022 · International Journal of Molecular Sciences
98. Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling
    Jörn Markus Schattenberg, Mark J. Czaja · 2014 · Redox Biology
99. Drug-induced liver injury in obesity and nonalcoholic fatty liver disease
    Julien Allard, Dounia Le Guillou, Karima Begriche, Bernard Fromenty · 2019 · Advances in pharmacology
100. Detrimental and protective fat: body fat distribution and its relation to metabolic disease
     Andrea D. Booth, Aaron M. Magnuson, Michelle T. Foster · 2014 · Hormone Molecular Biology and Clinical Investigation